OnabotulinumtoxinA for treatment of chronic migraine: a response

Headache. 2011 Jun;51(6):1005-8. doi: 10.1111/j.1526-4610.2011.01925.x. Epub 2011 May 17.

Authors

David W Dodick, Catherine C Turkel, Ronald E Degryse, Sheena K Aurora, Stephen D Silberstein, Richard B Lipton, Hans-Christoph Diener, Mitchell F Brin

PMID: 21592099
DOI: 10.1111/j.1526-4610.2011.01925.x

No abstract available

Publication types

Letter
Comment

MeSH terms

Botulinum Toxins, Type A / therapeutic use*
Humans
Migraine Disorders / drug therapy*
Neuromuscular Agents / therapeutic use*
Randomized Controlled Trials as Topic / standards*

Substances

Neuromuscular Agents
Botulinum Toxins, Type A